From The National Mental Health Consumers’ Self-Help Clearinghouse: For Complete Post, Click Here…
The Language That Clinicians Use Affects Recovery, Harvard Researchers Say
For decades, pharmaceutical companies have pitched the idea that depression is caused by a chemical imbalance. Now, a new study by Harvard researchers, in the Journal of Affective Disorders, suggests that, as clinical neuroscience language replaces psychotherapy vocabulary, expectations change and outcomes worsen for individuals in treatment.
“Chemical explanations of mental health appear to benefit pharmaceutical companies far more than patients,” according to a Big Think article, which includes a link to the study abstract. “More recent studies indicate that participants who are told that their depression is caused by a chemical imbalance or genetic abnormality expect to have depression for a longer period, report more depressive symptoms, and feel they have less control over their negative emotions,” the researchers write.
For the article, click here. And for “Let’s avoid talk of ‘chemical imbalance’: it’s people in distress,” in Psyche, which notes that “the growing endorsement of biological causation” has contributed to the prejudice and discrimination associated with mental health conditions, click here.